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Objectives: This study investigated current influenza vaccination rates among 
the urban Chinese population and high-risk adults. MethOds: This study included 
data from the 2013 China (N= 19,987) National Health and Wellness Surveys (NHWS), 
a cross-sectional, Internet-based survey. The NHWS includes a sample of urban (Tier 
I and II cities) adults (≥ 18 years) which included items on vaccination history and 
high-risk status defined by the World Health Organization(WHO). Vaccination rates 
and characteristics of vaccinees were reported descriptively. Logistic regressions 
were conducted to predict vaccination behavior from sociodemographics and risk-
related variables. Results: Only 13.69% of adults in urban China reported being 
vaccinated for influenza in 2013. Among patients in high-risk groups (coronary heart 
disease [CHD], chronic lung conditions etc.), vaccination rates were low for most 
groups, ranging from 5.7% (≥ 65 years) to 57.69% (chronic neurological conditions). 
The most common reason for non-vaccination was belief that it was not needed 
(17.8%); other common reasons for non-vaccination included believing that the vac-
cine is not effective (12.9%) and not getting a vaccine before (9%). Respondents who 
were vaccinated were less likely to be older (OR= 0.982), currently married (OR= 0.792) 
and university educated (OR= 0.748), and more likely to be female (OR= 1.403), 
a current smoker (OR= 1.387) exercised more on average (OR= 1.023), consumed alco-
hol regularly (OR= 2.299), feared needles more (OR= 1.111), and had higher incomes 
(RMB6,000 or more) (OR= 1.62) compared with those not vaccinated. The strongest 
predictors of vaccination were having CHD (OR= 2.161), chronic lung (OR= 2.069), 
chronic liver (OR= 1.891), chronic metabolic condition (OR= 1.835), or chronic renal 
conditions (OR= 1.758)(all p< .05). cOnclusiOns: Overall vaccination rates were low 
in China. Most WHO-recommended vaccination groups had rates less than 20% and 
a large gap remains between these recommendations and vaccination behavior. In 
2011, the influenza vaccination rates among adults in the United States were 36.2%, 
almost three times the vaccination rate in urban China.
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Objectives: Infection control and its Prevention system were established and 
its role, responsibility and right were clarified in Mongolia in May 4, 2010 by the 
decree of Minister of Health “Strengthening infection control system of Health 
care organizations and intensifying preventive actions of Hospital infections”. The 
Goal of this study is to implement a guideline for evaluation and development of 
Infection control and its Prevention activities of all levels of health care organiza-
tions. MethOds: 1. Method of cross sectional study was used in research of cur-
rent condition of Infection control Department activities. 2. Disinfection quality 
and safety was studied by Retrospective and Description methd. 3. Knowledge of 
disinfection and hand washing ofmedical staff are studied by descriptive and cross-
sectional study. Results: Assessment of current condition for activity of Infection 
control Department in national level was conducted among 6 tertiary level hospi-
tals, 8 secondary level hospitals and 28 primary level hospitals. cOnclusiOns: 
1. Infection control for department and teams at health care organizations work 
with proper structure of management and members, and their activities vary 
according to its level. 2. The health care organization’s hygiene standards and condi-
tions are different, especially disinfectants and equipment are inadequate. Medical 
stuff’s ability to hand disinfection is reduced according to its level. 3. Sterilizing 
quality is good enough, but its initial test and monitoring by technical methods are 
insufficient in primary health facilities. 4. 80.4% of medical staff attended infection 
control training and have adequate knowledge of hospital infections.
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Objectives: Globally, human immunodeficiency virus/acquired immune deficiency 
syndrome (HIV/AIDS) reduces life expectancy by several years. Mortality is high 
among non-treated patients. However, the predictors of mortality have not been 
adequately studied. Hence, the main objective of the study was to determine predic-
tors of mortality among HIV positive adults who are not on antiretroviral treatment, 
in a South Indian hospital. MethOds: A facility-based retrospective cohort study 
was conducted and data were collected from 150 patients who were registered 
but not on treatment from December 2011 to December 2013. Multiple logistic 
regression analysis was applied to identify the risk factors for mortality among 
HIV patients. Results: A total of 40 patients were died during the follow-up period. 
Patients with age between 39-59 years (OR 0.49, 95% CI 0.28-0.84), baseline World 
Health Organization (WHO) staging III and IV (OR 0.09, 95% CI 0.04-0.20 and OR 0.11, 
95% CI 0.04-0.27), patients with opportunistic infections (OR 4.93, 95% CI 2.87-8.84), 
were found to have less risk for mortality compared to their counterparts. Patients 
with low BMI (OR 2.05, 95% CI 1.21-3.49), CD4 count > 200 cells/µl (OR 3.88, 95% CI 
2.27-6.65) were found to have more risk. cOnclusiOns: Age group 18-38, patients 
without opportunistic infections, baseline WHO staging stage I and II, low BMI, CD4 
> 200 cells/µl were all significant predictors of mortality.  Therefore, patients with the 
aforementioned predictors should be followed closely and frequently.
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individuals or have no recommendations. The annual incidence of varicella in the 
general populations ranged from 13.7 to 76 per 100,000 in Asia-Pacific countries 
with universal vaccination, and from 100 to 512 per 100,000 in Asia-Pacific countries 
without universal vaccination. Studies in China, Japan, and South Korea showed 
varicella incidence peaking in spring and winter. Limited publication has reported 
varicella-related mortality in the Asia-Pacific region. Majority of the studies assess-
ing health care resource utilization focused on inpatient care. The most frequent 
complications among hospitalized patients were skin and respiratory complications. 
Hospitalization rates associated with varicella reported in Australia and Taiwan 
were 0.11 and 60 per 1,000 cases, respectively. Medical costs associated with varicella 
were estimated in China, Japan, Singapore, Taiwan, and Australia. cOnclusiOns: 
Epidemiology and economic burden of varicella in Asia-Pacific countries have not 
been extensively studied. Given limited varicella vaccination policy in this region, 
gaps in evidence need to be addressed to inform policy makers about the public 
health impact of varicella.
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Objectives: Influenza vaccination rates have not been high enough in Japan. This 
study investigated current influenza vaccination rates among the general Japan 
population and rates among high-risk adults. MethOds: This study included data 
from the 2011-2012 Japan (Ns= 30,000) National Health and Wellness Surveys(NHWS) 
a cross-sectional, Internet-bases survey.  The NHWS includes a nationwide sample 
of adults (18+ years) which included items on vaccination history as well as high-
risk group status as defined by the World Health Organization(WHO). Vaccination 
rates and characteristics of vaccinees were reported descriptively. Logistic regres-
sions were conducted to predict vaccination behavior from sociodemographics and 
risk-related variables. Results: 17.17% of adults in Japan reported being vaccinated 
for influenza in 2012(compared with 19.17% in 2011). Even among patients in high-
risk groups(CHD, chronic lung conditions etc.), vaccination rates were low, ranging 
from 24.83%(caregivers) to 42.86%(patients with immunodeficiencies). The most 
common reason for non-vaccination was the belief that it was not important(45.3%); 
other common reasons included believing that the vaccine is not effective (13.0%) 
and that prior infection leads to future resistance(12.3%). Respondents who were 
vaccinated were more likely to be female (OR= 1.006), older(OR= 1.212), univer-
sity educated(OR= 1.225), and employed(OR= 1.242) with higher incomes(¥5MM 
or more) (OR= 1.128) when compared to those who did not receive the vaccine. 
Those vaccinated also exercised more on average(OR= 1.006), and feared needles 
less(OR= 0.869). The strongest predictors of vaccination were having an immuno-
deficiency (OR= 3.613), heart disease (OR= 2.571), chronic lung(OR= 2.025), chronic 
liver(OR= 1.625), chronic renal condition(OR= 1.608) or chronic metabolic conditions 
(OR= 1.532) (all p< .05). cOnclusiOns: Overall vaccination rates were low in Japan 
with no increase in vaccination rates from the prior year. All WHO-recommended 
vaccination groups had rates less than 50% and a large gap remains between these 
recommendations and vaccination behavior. In 2011, the influenza vaccination 
rates among adults in the United States were 36.2%, almost twice the vaccination 
rate in Japan.
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Objectives: To assess the prevalence of health care-associated infection (HAI) 
in 2012 among grade A hospitals in China. MethOds: Literatures were searched 
from PubMed, EMBASE, Cochrane Library, CNKI, cqvip, WANFANG, and SinoMed 
from Jan. 2012 to Mar. 2014. Literatures were screened and data was extracted by 
two independent reviewers, separately. Meta-analyses were conducted by R3.0.3 
with random effect models. Results: Fifty studies with 91,763 patients met the 
inclusion criteria and were included. The overall prevalence rate of HAI among all 
studies was 3.4% (95% CI: 3.1%-3.8%). Among the 50 studies, 25 were performed in 
Grade A tertiary hospitals and the rest 25 in grade A level 2 hospitals. The 25 studies 
performed in Grade A tertiary hospitals including 26,700 participants reported the 
pooled HAI prevalence as 3.5% (95% CI: 3.0%-4.1%). The aggregated HAI prevalence 
of the other 25 studies with 65,063 patients in grade A level 2 hospitals was 3.2% 
(95% CI: 2.7%-3.8%), which was not significantly different from that in Grade A 
tertiary hospitals (P= 0.32). In the analyses of different infection sites, 18 studies 
targeting at lower respiratory infection (19,035 participants) revealed the highest 
combined constituent ratio as 46.6% (95% CI: 40.1%-52.3%). The pooled constituent 
ratio of 17 studies targeting at urinary system infection (19,949 participants) was 
16.1% (95% CI: 11.5%-22.1%) and that of 19 studies targeting at upper respiratory 
infection (20,924 participants) was 15.2% (95% CI: 11.2%-20.2%). In the analyses of 
antibiotics using, 18 studies were identified (19,090 participants) in grade A ter-
tiary hospitals and revealed pooled antibiotics using ratio as 42.96% (95% CI: 38.3%-
47.8%). cOnclusiOns: The aggregated prevalence rate of HAI was 3.4% across all 
general hospitals. The pooled prevalence rate among grade A tertiary hospitals and 
grade A level 2 hospitals showed no significant difference. Among all infection sites, 
lower respiratory infection accounts for the highest proportion.
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